1
项与 CART-38(The First Affiliated Hospital of Soochow University) 相关的临床试验Pilot Study of the Efficacy and Safety of CD38 Targeted Chimeric Antigen Receptor Engineered T-Cells in the Treatment of CD38 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
This is a single center, open-label phase 1/2 study to evaluate the safety and efficacy of targeted CD38 chimeric antigen receptor engineered T cell immunotherapy (CART) in the treatment of CD38 positive relapsed or refractory acute myeloid leukemia.
100 项与 CART-38(The First Affiliated Hospital of Soochow University) 相关的临床结果
100 项与 CART-38(The First Affiliated Hospital of Soochow University) 相关的转化医学
100 项与 CART-38(The First Affiliated Hospital of Soochow University) 相关的专利(医药)
100 项与 CART-38(The First Affiliated Hospital of Soochow University) 相关的药物交易